Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Leafly | LFLY | Sep 19, 2024 | 1.79 | +0.56 |
Leap Therapeutics | LPTX | Sep 19, 2024 | 2.84 | -1.39 |
Lear | LEA | Sep 19, 2024 | 110.02 | +2.62 |
Learn CW Investment SPAC | LCW | Sep 19, 2024 | 10.98 | 0.00 |
LeddarTech | LDTC | Sep 19, 2024 | 0.30 | +9.16 |
Lee Enterprises | LEE | Sep 19, 2024 | 8.61 | +4.87 |
Legacy Housing | LEGH | Sep 19, 2024 | 28.86 | +3.18 |
LegalZoom.com | LZ | Sep 19, 2024 | 6.70 | +0.45 |
Legato Merger III | LEGT | Sep 19, 2024 | 10.20 | +0.05 |
Legend Biotech ADR | LEGN | Sep 19, 2024 | 50.83 | +1.84 |
Legg Mason Low Volatility High Dividend ETF | LVHD | Sep 19, 2024 | 40.41 | +0.07 |
Leggett & Platt | LEG | Sep 19, 2024 | 13.55 | +2.96 |
Leidos | LDOS | Sep 19, 2024 | 156.09 | +1.50 |
LeMaitre Vascular | LMAT | Sep 19, 2024 | 90.18 | +1.50 |
Lemonade | LMND | Sep 19, 2024 | 18.42 | +1.10 |
LendingClub | LC | Sep 19, 2024 | 11.52 | +5.30 |
LendingTree | TREE | Sep 19, 2024 | 59.84 | +2.92 |
Lendway | LDWY | Sep 19, 2024 | 3.86 | +1.45 |
Lennar A | LEN | Sep 19, 2024 | 192.45 | +2.13 |
Lennar B | LEN-B | Sep 19, 2024 | 176.65 | +2.35 |
Lennox International | LII | Sep 19, 2024 | 616.47 | +2.33 |
LENSAR | LNSR | Sep 19, 2024 | 4.31 | +2.62 |
LENZ Therapeutics | LENZ | Sep 19, 2024 | 22.08 | +2.70 |
Leonardo DRS | DRS | Sep 19, 2024 | 28.19 | +2.10 |
Lesaka Technologies | LSAK | Sep 19, 2024 | 4.55 | 0.00 |
Leslies | LESL | Sep 19, 2024 | 3.01 | +5.99 |
Levi Strauss & Co A | LEVI | Sep 19, 2024 | 19.92 | +0.71 |
Lexaria Bioscience | LEXX | Sep 19, 2024 | 3.15 | -2.17 |
Lexeo Therapeutics | LXEO | Sep 19, 2024 | 10.42 | +8.77 |
Lexicon Pharmaceuticals | LXRX | Sep 19, 2024 | 1.69 | +3.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.